Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Chiesi USA, Inc.

NC, United States

CMS manufacturer 100000010860

Open in the dashboard

General payments

$23,210,744

66,292 payments

Research payments

$60,670,583

16,612 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Chiesi USA, Inc. reported paying $23,210,744 in general payments and $60,670,583 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $7,720,689 10,606
2025 Research $1,163,509 689
2024 General $5,387,373 9,915
2024 Research $25,436,715 6,565
2023 General $2,537,672 8,212
2023 Research $24,735,647 6,827
2022 General $2,428,733 10,668
2022 Research $4,491,516 1,096
2021 General $1,717,890 11,795
2021 Research $2,161,957 501
2020 General $1,683,969 5,536
2020 Research $676,962 209
2019 General $1,734,419 9,560
2019 Research $2,004,278 725

Breakdown

Top recipients General payments · program year 2025
  1. Hospital Of The Univ Of Penna Teaching hospital · PA $3,776,366 4 payments
  2. Massachusetts General Hospital Teaching hospital · MA $232,047 11 payments
  3. Qais Abu Ali Internal Medicine · Canton, OH $135,950 8 payments
  4. The Childrens Hospital Of Philadelp Teaching hospital · PA $135,500 3 payments
  5. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $120,766 3 payments
  6. University Of Washington Med Ctr Teaching hospital · WA $107,875 3 payments
  7. Washington Hospital Center Teaching hospital · DC $103,900 5 payments
  8. Kfh - Oakland Teaching hospital · CA $97,437 2 payments
  9. Gerald Cox Clinical Genetics (M.D.) · Boston, MA $96,010 7 payments
  10. Marianne Mann Internal Medicine · Highland, MD $95,825 11 payments
Top research recipients Research payments · program year 2025
  1. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $196,965 109 payments
  2. The Childrens Hospital Of Philadelp Teaching hospital · PA $131,191 67 payments
  3. Lysosomal And Rare Disorders Research And Treatment Center Inc $95,379 1 payment
  4. Direct Helpers Research Center $89,456 35 payments
  5. Massachusetts General Hospital Teaching hospital · MA $70,524 82 payments
  6. University Of Texas Southwestern Medical Center $54,193 20 payments
  7. Renal Disease Research Institute $47,477 2 payments
  8. Children's Healthcare Of Atlanta INC $43,662 13 payments
  9. Chandler Clinical Trials LLC $34,491 22 payments
  10. The University Of Texas Southwestern Medical Center $33,592 14 payments
Products the payments named General payments · program year 2025
  1. Juxtapid Homozygous Familial Hypercholesterolemia $3,856,236 62% · 423 recipients
  2. Cleviprex Cardiovascular $492,083 8% · 3,206 recipients
  3. Kengreal Cardiovascular $477,822 8% · 2,257 recipients
  4. Mycapssa Acromegaly $411,579 7% · 921 recipients
  5. Curosurf Neonatology $372,014 6% · 485 recipients

The top 5 of 11 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $383,212 15% · 350 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $334,052 13% · 543 practitioners
  3. Pulmonary Disease Internal Medicine $243,960 9% · 111 practitioners
  4. Clinical Genetics (M.D.) Medical Genetics $182,661 7% · 33 practitioners
  5. Interventional Cardiology Internal Medicine $170,817 7% · 445 practitioners

The top 5 of 132 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $4,033,728 52% · 170 recipients
  2. Massachusetts $558,397 7% · 90 recipients
  3. California $387,180 5% · 539 recipients
  4. Ohio $375,274 5% · 268 recipients
  5. New York $247,893 3% · 703 recipients

The top 5 of 52 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $5,751,267 992 payments
  2. Royalty or License $5,522,318 8 payments
  3. Grant $4,237,347 163 payments
  4. Honoraria $2,061,075 1,152 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,947,921 762 payments
  6. Food and Beverage $1,523,441 56,065 payments
  7. Travel and Lodging $1,174,334 2,276 payments
  8. Space rental or facility fees (teaching hospital only) $705,749 343 payments
  9. Charitable Contribution $130,229 30 payments
  10. Education $95,138 3,583 payments
66,292 general · 16,612 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record